secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2022-01-14T23:59:59+00:00
Accession:  0001683168-22-000270
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals grants 30,000 stock options each to CEO, CFO, COO and directors
--------------------------------------------------------------------------------

- Annual grant of stock options to employees, executive officers, and directors on January 14, 2022.
- Exercise price set at $4.57 per share, based on closing price on grant date.
- Options vest in three equal tranches at 6, 18, and 30 months; full vesting upon change of control.
- CEO Amy Trombly, CFO Jerry Dvonch, and COO Bruce Thornton each received 30,000 options.
- Each director also received 30,000 options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316822000270/0001683168-22-000270-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316822000270/snoa_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-000270

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer